Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ILKN421H |
| Synonyms | |
| Therapy Description |
ILKN421H is a lipid nanoparticle-formulated mRNA encoding an IL2Rbeta-gamma-selective IL2v, which potentially induces CD8-positive T-cell and NK cell proliferation and antitumor immune activity (J Clin Oncol 2026 44: 16_suppl, 8556). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ILKN421H | ILKN-421H|ILKN 421H | ILKN421H is a lipid nanoparticle-formulated mRNA encoding an IL2Rbeta-gamma-selective IL2v, which potentially induces CD8-positive T-cell and NK cell proliferation and antitumor immune activity (J Clin Oncol 2026 44: 16_suppl, 8556). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|